Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: Is bolus dose amiodarone an appropriate first-line treatment?

Emergency Medicine Journal

Volumn 25, Issue 1, 2008, Pages 15-18

  Tomlinson, D R ^a   Cherian, P ^a   Betts, T R ^a   Bashir, Yaver ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

AGED; ARTICLE; BOLUS INJECTION; CARDIOVERSION; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DRUG FATALITY; DRUG TREATMENT FAILURE; EMERGENCY CARE; FEMALE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THROMBOPHLEBITIS; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 38749115783     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.051086     Document Type: Article

References (24)

1. Nolan JBP, Gabbott D, et al. Resuscitation Council (UK) advanced life support course provider manual. 4th ed. London: Resuscitation Council (UK), 2000.
2. American Heart Association. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: Advanced cardiovascular life support: Section 5: Pharmacology I: Agents for arrhythmias. American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000;102(8 Suppl):I1 12-28.
3. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996;27:67-75.
4. Kowey PR, Levine JH, Herre JM, et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995; 92:3255-63.
5. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995;92:3264-72.
6. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-90.
7. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
8. Griffith MJ, Garratt CJ, Mounsey P, et al. Ventricular tachycardia as default diagnosis in broad complex tachycardia. Lancet 1994;343:386-8.
9. de Bakker JM van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988;77:589-606.
10. Wellens HJ, Brugada P, Abdollah H, et al. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Circulation 1984;69:120-4.
11. Kosinski EJ, Albin JB, Young E, et al. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 1984;4:565-70.
12. Scheinman MM, Levine JH, Cannom DS, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995;92:3264-72.
13. Marill KA, deSouza IS, Nishijima DK, et al. Amiodarone is poorly effective for the acute termination of veotricular tachycardia. Ann Emerg Med 2006;47:217-24.
14. Armengol RE, Graff J, Baerman JM, et al. Lack of effectiveness of lidocaine for sustained, wide QRS complex tachycardia. Ann Emerg Med 1989;18:254-7.
15. Ho DS, Zecchin RP, Richards DA, et al. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. Lancet 1994;344:18-23.
16. Gorgels AP, van den Dool A, Hofs A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996;79:43-6.
17. Morady F, DiCarlo LA Jr., de Buitleir M, et al. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia. Circulation 1986;74:1355-64.
18. Marill KA, Greenberg GM, Kay D, et al. Analysis of the treatment of spontaneous sustained stable ventricular tachycardia. Acad Emerg Med 1997;4:1122-8.
19. International Liaison Committee on Resuscitation. Part 4: Advanced life support. Resuscitation 2005;67:214-47.
20. Resuscitation Council (UK). Peri-arrest arrhythmias. Resuscitation Guidelines, 2005:59-67.
21. Schurtzenberger W, Leisch F, Kerschner K, et al. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. Br Heart J 1989;62:367-71.
22. Mooss AN, Mohiuddin SM, Hee TT, et al. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990;65:609-14.
23. Somberg JC, Bailin SJ, Haffajee CI, et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol 2002; 90:853-9.
24. American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology. Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-484.